Janux Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Janux Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Janux Therapeutics Inc
Rating: 1.49816675
Author: Trendlyne DVM scores

about

Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (...

26.48 -2.18 (-7.61%)

63.07% Fall from 52W High

1.8M

XNAS Volume

XNAS 07 Nov, 2025 4:30 PM (EST)

Not Eligible

Expensive Valuation

11.2 / 100

Technically Neutral

48.8 / 100

1Yr Price target upside is 196%

17 analysts

Janux Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Janux Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (...

63.07% Fall from 52W High

SWOT Analysis

Janux Therapeutics Inc Live Price Chart